Corymbia maculata
Corymbia maculata · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Corymbia maculata is a significant botanical species that has drawn scientific interest due to its diverse pharmacological potential. Research focusing on the stem of this plant has utilized both chloroformic extracts and crude extracts to investigate its therapeutic properties. Chemical analyses of these preparations have identified key bioactive compounds, including cinnamic acid and sakuranetin. These constituents contribute to a complex biological profile characterized by (-)-chronotropic, (-)-inotropic, ACE-inhibitor, and AChE-inhibitor activities. Consequently, understanding the chemical makeup of Corymbia maculata provides essential insights into its medicinal applications.
- Synonyms
- Eucalyptus Maculata · Blakella Maculata
- Common names
- Not available
- Family
- Myrtaceae
- Distribution
- Not available
- Plant Parts
- Stem
Classification
Synonyms
Corymbia maculata is a botanical species that is frequently identified by various names depending on the taxonomic classification used. Within scientific literature, it is officially recognized as a synonym of Blakella maculata. Furthermore, the plant is often referred to under the synonym Eucalyptus maculata in older or alternative records. These varying nomenclatures highlight the evolving nature of botanical relationships and classification systems. Understanding these synonymous connections is essential for accurate identification in both academic and field studies.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Corymbia maculata is a distinguished member of the kingdom Plantae. This botanical species is classified under the class Equisetopsida. Within its biological hierarchy, it belongs to the order Myrtales. It is further categorized under the family Myrtaceae, which highlights its evolutionary connections. Finally, the plant is a representative of the genus Corymbia.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Myrtales |
| Family | Myrtaceae |
| Genus | Corymbia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Corymbia maculata is a species with a broad geographic presence across several regions of the African continent. Its distribution includes East Tropical Africa, where it can be found in Kenya, Tanzania, and Uganda. Moving southward, the plant also inhabits parts of South Tropical Africa, specifically within Zambia. Additionally, its range extends into the Southern African region, covering the Cape Provinces. This diverse spread highlights the plant's ability to adapt to various ecological zones throughout Africa.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Corymbia maculata is a robust tree characterized by its impressive and self-supporting growth form. This species can reach substantial heights, typically ranging from a minimum of 25 meters to a maximum of 60 meters. In many instances, the tree establishes a more significant presence with a minimum height of approximately 30 meters. Its sturdy structure allows it to dominate much of its natural landscape effectively. Ultimately, this impressive stature makes it a prominent feature of its ecosystem.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Corymbia maculata, also known as Eucalyptus maculata, serves as a rich source of various bioactive phenolic constituents. Research into the resinous exudates from its stems has successfully identified several specific chemical components. Among these isolated substances, cinnamic acid plays a significant role in the plant's chemical profile. Additionally, the presence of sakuranetin has been confirmed through detailed spectroscopic analysis. These findings highlight the complex chemical makeup inherent to this particular species.
Conditions
Corymbia maculata, through its resin extracts, demonstrates significant inhibitory effects on several key inflammatory targets. Specifically, the plant's bioactive compounds treat COX-2 and cyclooxygenase-1 (COX-1) to mitigate inflammatory responses. It also effectively treats NF-B and TNF- to help regulate immune signaling pathways. Additionally, the extracts are shown to treat NO, contributing to a broad anti-inflammatory profile. These diverse relationships highlight the plant's potential as a source for potent therapeutic agents.
Preparations
Corymbia maculata is prepared as a chloroformic extract to isolate specific phenolic constituents from its resinous stem exudate. This particular extraction process has successfully yielded compounds such as cinnamic acid, 7-methyl aromadendrin, and sakuranetin. Additionally, the species is prepared as crude extracts to facilitate the screening of bioactive principles against kinetoplastid parasites. These crude preparations, including those using hexane, ethyl acetate, and methanol, have demonstrated promising activity against drug-resistant Trypanosoma brucei. Through these diverse preparation methods, researchers can isolate specific triterpenoids that show significant efficacy and low toxicity.
Parts used
Corymbia maculata possesses a specialized stem structure that serves as a vital source of unique chemical compounds. Within the resinous exudate of these stems, researchers have identified various significant phenolic constituents. Through the use of chloroformic extraction, scientists successfully isolated four distinct substances from this specific plant part. These include a newly discovered di-cinnamic acid glucose ester alongside cinnamic acid, 7-methyl aromadendrin, and sakuranetin. Advanced analytical techniques like NMR and MS were essential in elucidating the complex molecular structures found within the stem.